ACROMEGALY STUDY

United States

ACROMEGALY TREATMENT 24 HOURS 1 DOSE

A clinical study for an ORAL, ONCE-DAILY acromegaly treatment is looking for participants.

INTERESTED PARTICIPANTS MUST:
- Be 18 years of age or older
- Have medically stable, confirmed-active acromegaly
- Be on an approved, stable dose of long-acting octreotide or lanreotide, for at least 12 weeks prior to screening

INTERESTED PARTICIPANTS MAY RECEIVE:
- Study-related care and study medication at no cost
- Reimbursement for travel (patient +1)

By signing up you agree to receive text messages and emails about this and similar studies near you. You can unsubscribe at any time. Text messages and data rates may apply. You also agree that StudyKIK may provide your personal information to the sponsor of this study or the research site to help determine if you qualify for study. Please refer to StudyKIK's Privacy Policy and Terms of Service for more information.